Teva to send US millions of malaria pills with potential to help COVID-19 | The Times of Israel

Israeli generic drug giant Teva announced Friday that it will provide ten million doses of its anti-malarial drug hydroxychloroquine, which could potentially prove effective in fighting the coronavirus pandemic, to US hospitals free of charge. The company said six million doses will be delivered to US hospitals by March 31, and more than ten million in a month. “We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” Teva executive vice president Brendan O’Grady said. US President Donald Trump…

Read More